Product
  • Product
  • Supplier
  • Inquiry

    EN

    Home > Chemical News > COVID-19

    Articles Related to COVID-19

    Growth in major Asian economies drives demand for petrochemical products

    Growth in major Asian economies drives demand for petrochemical products

    The COVID-19 epidemic has severely affected the global economy in 2020. GlobalData said that the growth of major Asian economies is expected to rebound in 2021
    Will influenza vaccine be difficult to get under the epidemic situation?

    Will influenza vaccine be difficult to get under the epidemic situation?

    The high incidence season of influenza is from November to march of the next year. Since it usually takes 2 to 4 weeks to produce antibody with protective level in human body after vaccination, September to October every year is the best time for influenz
    The pace of the current global energy transition has been quite fast

    The pace of the current global energy transition has been quite fast

    "The novel coronavirus has changed the global energy outlook, but the global climate crisis is still as urgent as before the epidemic," said Remi Eriksen, President and CEO of DNV GL Group.
    IMF: 2020 global oil demand may decrease by 8%

    IMF: 2020 global oil demand may decrease by 8%

    The International Monetary Fund (IMF) recently stated in a new update report that the novel coronavirus crisis will cause global oil demand this year to drop by approximately 8% year-on-year.
    The anti COVID-19 performance of seaweed extract is much better than remdesivir

    The anti COVID-19 performance of seaweed extract is much better than remdesivir

    Earlier this year, the news that Gilead’s antiviral drug Remdesivir (Remdesivir) cured American patients with new coronary pneumonia made people have great expectations for this drug.
    Pfizer and BioNTech choose lead mRNA vaccine candidate against COVID-19

    Pfizer and BioNTech choose lead mRNA vaccine candidate against COVID-19

    Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the start of a global (except for China) Phase 2/3 safety and efficacy clinical study.
    Moderna's rumored $50-plus price on COVID-19 vaccine draws ire as company touts

    Moderna's rumored $50-plus price on COVID-19 vaccine draws ire as company touts

    Moderna has yet to confirm its pricing plan for its phase 3 COVID-19 vaccine, but that hasn't stopped analysts and politicians from debating how it and its rivals should strike the right balance between public health and profitability.
    moderna Vaccine COVID-19

    2020-07-31

    Why did the import of whey powder grow against the trend during the epidemic?

    Why did the import of whey powder grow against the trend during the epidemic?

    Since the global outbreak of the new crown pneumonia epidemic, the normal supply of global agricultural products has been disrupted, and the international trade of most agricultural products has fallen sharply.
    Pfizer, BioNTech snare $1.95B deal with U.S. government for COVID-19 vaccine

    Pfizer, BioNTech snare $1.95B deal with U.S. government for COVID-19 vaccine

    The Trump administration's Warp Speed initiative has placed its biggest bet yet on an accelerated COVID-19 vaccine—and Pfizer and BioNTech are the lucky recipients.
    Pfizer COVID-19 Vaccine

    2020-07-24

    India's spice export data released, greatly affected by the epidemic

    India's spice export data released, greatly affected by the epidemic

    The Indian Chamber of Commerce and Industry released data on July 19 that India’s spice exports in June increased to US$359 million (approximately 26.9 billion Indian rupees), an increase of 23% from US$292 million in the same period last year.
    Spices India data COVID-19

    2020-07-21

    Chinese firm builds $79M COVID-19 vaccine plant, eyes production next year

    Chinese firm builds $79M COVID-19 vaccine plant, eyes production next year

    On Saturday, China’s AIM Vaccine Group broke ground on a manufacturing and R&D base for its coronavirus vaccine in the city of Ningbo. The company is investing CNY 550 million ($79 million) on the project
    COVID-19 Vaccine China

    2020-07-20

    Suggestions
    Email:
    Message:
    Send Message